🔎 Trials Near Me

Akèy › Kansè kol › Kalifòni › Los Angeles

Etid klinik pou Kansè kol nan Los Angeles, CA

16 etid pou Kansè kol ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Ap rekriteFaz 1
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06465069

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Ap rekriteFaz 1/2
  • University of Southern California, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Ap rekriteFaz 1
  • START - Los Angeles, Los Angeles
  • Cedars Sinai, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers

Ap rekrite
  • University of California at Los Angeles, Los Angeles
Laj 18 ak plis · Fanm · Mizajou Aug 20, 2026 · NCT06538337

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • USC/Norris Comprehensive Cancer Center, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT04895709

A Study of MGC026 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • The Angeles Clinic and Research Institute, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06242470

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Ap rekriteFaz 1/2
  • Los Angeles Cancer Network, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06330064

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

Ap rekrite
  • UCLA Gynecologic Oncology Clinic, Los Angeles
Laj 18 ak plis · Fanm · Mizajou Jul 30, 2026 · NCT04831580

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Ap rekriteFaz 1
  • START Los Angeles, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07524322

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Ellison Clinic at Saint John's, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ap rekriteFaz 1
  • Ronald Reagan UCLA Medical Center, Los Angeles
  • The Regents of the University of California, Los Angeles
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632

A Study of VET3-TGI in Patients With Solid Tumors

Ap rekriteFaz 1
  • USC/Norris Comprehensive Cancer Center, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Apr 7, 2026 · NCT06444815

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Ap rekriteFaz 1/2
  • University of Southern California, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Dec 11, 2025 · NCT06943521

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Research Site 125, Los Angeles
  • Research Site 133, Los Angeles
  • Research Site 103, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT05914116

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Cedars Sinai Medical Center, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2025 · NCT05941507

A Study of NX-1607 in Adults With Advanced Malignancies

Ap rekriteFaz 1
  • University of Southern California, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT05107674

Etid Kansè kol nan lòt vil

Lòt etid nan Los Angeles

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.